Skip to main content

Incyte OPZELURA revenue

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

OPZELURA revenue at Incyte came to $254.9M for the quarter to 30 Sep 2026, up 35.6% from a year earlier.

As Incyte reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$109.2MDec 2023$85.7MMar 2024$121.7MJun 2024$139.3MSep 2024$161.6MDec 2024$118.7MMar 2025$164.5MJun 2025$188.0MSep 2025$207.3MDec 2025$143.0MMar 2026$449.7MJun 2026$254.9MSep 2026
Incyte OPZELURA revenue, every reported period
Period endingOPZELURA revenueChange on a yearFiled
30 Sep 2026$254.9Mup 35.6%29 Oct 2026
30 Jun 2026$449.7Mup 173.4%28 Jul 2026
31 Mar 2026$143.0Mup 20.5%28 Apr 2026
31 Dec 2025$207.3Mup 28.3%10 Feb 2026
30 Sep 2025$188.0Mup 35.0%28 Oct 2025
30 Jun 2025$164.5Mup 35.2%29 Jul 2025
31 Mar 2025$118.7Mup 38.5%29 Apr 2025
31 Dec 2024$161.6Mup 47.9%10 Feb 2025
30 Sep 2024$139.3Mup 51.7%29 Oct 2024
30 Jun 2024$121.7Mup 51.7%30 Jul 2024
31 Mar 2024$85.7Mup 51.6%30 Apr 2024
31 Dec 2023$109.2M—13 Feb 2024
30 Sep 2023$91.8Mup 140.8%31 Oct 2023
30 Jun 2023$80.2Mup 384.5%1 Aug 2023
31 Mar 2023$56.6Mup 343.4%2 May 2023
30 Sep 2022$38.1M—1 Nov 2022
30 Jun 2022$16.6M—2 Aug 2022
31 Mar 2022$12.8M—3 May 2022
30 Sep 2021$0—2 Nov 2021

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Incyte: Customer A (change on a year) · Customer B (change on a year) · Customer C (change on a year) · JAKAFI revenue · Product royalty revenues · JAKAVI revenue · NIKTIMVO revenue · ZYNYZ revenue · MINJUVI/MONJUVI revenue · Milestone and contract revenues · OLUMIANT revenue · ICLUSIG revenue · PEMAZYRE revenue · TABRECTA revenue · United States revenue · Europe revenue · financial statements

Every KPI and segment of INCY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.